Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19

Therapeutic options for coronaviruses remain limited. To address this unmet medical need, we screened 5406 compounds, including United States Food and Drug Administration (FDA)-approved drugs and bioactives, for activity against a South Korean Middle East respiratory syndrome coronavirus (MERS-CoV)...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Viruses
Hoofdauteurs: Ko, Meehyun, Chang, So Young, Byun, Soo Young, Ianevski, Aleksandr, Choi, Inhee, Pham Hung d’Alexandry d’Orengiani, Anne-Laure, Ravlo, Erlend, Wang, Wei, Bjørås, Magnar, Kainov, Denis E., Shum, David, Min, Ji-Young, Windisch, Marc P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8069929/
https://ncbi.nlm.nih.gov/pubmed/33918958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13040651
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items